Etilevodopa
![]() | |
![]() | |
| Clinical data | |
|---|---|
| ATC code | N04BA06 (WHO) (combination with decarboxylase inhibitor) |
| Identifiers | |
| |
| CAS Number |
37178-37-3 |
| PubChem (CID) | 170345 |
| ChemSpider |
148944 |
| UNII |
895X917GYE |
| KEGG |
D04097 |
| ECHA InfoCard | 100.223.003 |
| Chemical and physical data | |
| Formula | C11H15NO4 |
| Molar mass | 225.241 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
Etilevodopa (TV-1203) is a dopaminergic agent which was developed as a treatment for Parkinson's disease.[1] It is the ethyl ester of levodopa. It was never marketed.
See also
References
- ↑ Djaldetti Ruth; Giladi Nir; Hassin-Baer Sharon; Shabtai Hertzel; Melamed Eldad (November–December 2003). "Pharmacokinetics of Etilevodopa Compared to Levodopa in Patient's With Parkinson's Disease: An Open-label, Randomized, Crossover Study". Clinical Neuropharmacology. 26 (6): 322–326. doi:10.1097/00002826-200311000-00012.
| Dopaminergics |
| ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anticholinergics | |||||||||||||||||||
| Others | |||||||||||||||||||
| |||||||||||||||||||
| Phenethylamines |
|
|---|---|
| Amphetamines |
|
| Phentermines |
|
| Cathinones |
|
| Phenylisobutylamines | |
| Phenylalkylpyrrolidines | |
| Catecholamines (and close relatives) |
|
| Miscellaneous |
|
This article is issued from Wikipedia - version of the 5/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

